Inactive Instrument

ICON plc Stock Nasdaq

Equities

US45103T1079

Biotechnology & Medical Research

End-of-day quote Nasdaq Other stock markets
- ^USD	-

on all our subscriptions*

Exceptional extension!

Take advantage of the offer

* See conditions on site

Press releases ICON plc

ICON plc : ICON and DIA to Deliver Webinar on Clinical Outcome Assessments	13-09-03	PU
ICON plc : ICON Launches New Monitoring Service to Improve Quality and Reduce Costs	13-08-21	PU
ICON plc : ICON Signs Collaboration Agreement with the Taiwan National Centre of Excellence for Clinical Trials and Research	13-08-07	PU
ICON plc : ICON Reports second quarter 2013 Revenue of $334 million, up 21% year on year, non-GAAP EPS of 43c and raises FY 2013 Guidance.	13-07-25	PU
ICON plc : ICON shareholders vote in favour of all resolutions at its Annual General Meeting	13-07-23	PU

More press releases

News in other languages on ICON plc

Icon : annonce l'achèvement d'un "fractionnement d'actions"

08-08-14

Company Profile

Sector

Biotechnology & Medical Research

More about the company

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MODERNA, INC.	+44.48%	54.04B
LONZA GROUP AG	+43.57%	41.96B
IQVIA HOLDINGS INC.	-0.86%	41.92B
CELLTRION, INC.	-7.59%	28.35B
ICON PUBLIC LIMITED COMPANY	+12.30%	26.35B
ALNYLAM PHARMACEUTICALS, INC.	-21.83%	19B
BIO-TECHNE CORPORATION	+7.15%	13B
MEDPACE HOLDINGS, INC.	+29.40%	12.28B
UNITED THERAPEUTICS CORPORATION	+25.15%	12.19B

Other Biotechnology & Medical Research

-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.

BENEFIT NOW